entertainment -WSS

entertainment

author：explore 2025-09-05 11:32:36 - browse：8

A purple number 3 with an eye is surrounded by smaller, black number 3s on a green background — 3 to watch coverage from STAT — Christine Kao/STAT

Every winter, like Punxsutawney nobles, biotech’s many thought leaders gather for the J.P. Morgan Healthcare Conference to pick apart the year that was and prognosticate about the one to come. The consensus, in good markets and bad, is almost always cautious optimism for boom times ahead, a prediction that in recent years has had groundhog-level accuracy.

But after two years of steady decline, 2024 might finally prove them right. Biotech is on the upswing, driven by the rise of some headline-grabbing medicines, the advance of cutting-edge technologies, and a few reminders that big drug companies are still willing to pay billions of dollars for small ones.

Here are three major themes that we expect to drive the news in 2024 and determine whether biotech’s comeback is a sustainable trend or an interest-rate phenomenon.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare details structure of new drug price negotiation program
Next article： Pharma needs to include young adults in clinical research

WSS

New company forms to vet health AI models, root out weaknesses

Key Senate committee drafts bipartisan bill to stem drug shortages

Special counsel alerts court to Trump’s social media post

Cancer researcher Catriona Jamieson is sending tumors into space

Pope greeted like rockstar, appears revitalized at 'Catholic Woodstock' in Portugal

Flash flooding emergencies prompt evacuations in Kentucky, Tennessee

leisure time

entertainment

entertainment

Wildfire smoke exposes gaps in outdoor worker protections

What to know about 'Guardians of the Galaxy Vol. 3' as it hits Disney+

New air purifier tech could be key to improving indoor air quality

Tuesday set an unofficial record for the hottest day on Earth. Wednesday may break it.

How one medical school became remarkably diverse

Flash flooding emergencies prompt evacuations in Kentucky, Tennessee

Psychedelics group wrestles with new pharma identity

Cholera vaccine supply gets boost as demand surges globally

Hepatitis C has a cure — but many Americans still lack access to it

Pope greeted like rockstar, appears revitalized at 'Catholic Woodstock' in Portugal

hotspot

Q&A: Jennifer Adair on making gene therapy available globally

Pharma needs to include young adults in clinical research

Melinda French Gates resigns from Gates Foundation

Diversity in clinical trials starts with building trust, experts say

H5N1 bird flu virus started spreading in cows in Texas in December

Key Senate committee drafts bipartisan bill to stem drug shortages

leisure time

explore

focus

hotspot